Wave Life Sciences Ltd (WVE) shares are currently priced at $9.51. Investors considering alternative strategies might find selling the April 2026 put at a $7.50 strike appealing, with a bid of $1.30, representing a 17.3% return based on the $7.50 commitment and an annualized 26.5% rate of return. The put seller only benefits from the premium unless the stock falls 21.1%, leading to a cost basis of $6.20 per share after the premium.
The trailing twelve-month volatility for Wave Life Sciences is calculated at 100%. On Thursday, mid-afternoon trading observed a put volume of 957,084 contracts among S&P 500 components, with an equal call volume, resulting in a put:call ratio of 0.71, exceeding the long-term median of 0.65, indicating more put buyers than expected.
